Although knowledge of cancer biology in the laboratory has increased exponentially in recent years, progress in cancer treatment in the clinic has been more gradual. To accelerate progress in the clinic, a larger number of outstanding clinician-investigators is needed to perform patient-oriented, therapeutic translational research. The M. D. Anderson (MDACC) K12 Paul Calabresi Program in Clinical Oncology has taken advantage of an extraordinary environment for clinical and translational research to begin to fill this need. MDACC brings together 1,469 faculty and 29,500 new patients each year with a well-developed infrastructure for clinical and laboratory research and novel ideas that are supported by 254 NCI grants. For 6 decades, MDACC investigators have made important contributions to clinical cancer research. Since the inception of the MDACC K12 Program in 2000, 9 junior-faculty investigators have been trained in patient- based translational research with the program's support. Currently four faculty investigators and two fellows are being trained in this program. All nine of our graduates have become highly productive clinician- scientists, who have published 388 peer-reviewed papers, competed successfully for $10.9 M in grants and contracts and have headed 89 therapeutic protocols. The four faculty and two fellow trainees supported by this award will conduct hypothesis driven clinical trials, participate in a cancer-oriented K30 curriculum and can earn an M.S./Ph.D. in Patient-Based Biological Research. To maximize use of MDACC's extensive resources for clinical, translational and basic research, this combined K12 program will include fellows and junior faculty not only from MDACC but also from the Baylor College of Medicine. This program emphasizes individualized training plans that include didactic classes, clinical trials, laboratory research projects, publication of results, individualized training experiences, and long-range planning. Each Calabresi scholar is guided by a clinical mentor and a translational mentor as well as by the PI and the program's Advisory Committee, composed of experts in clinical, laboratory, and translational research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA088084-15
Application #
8731625
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (J))
Program Officer
Damico, Mark W
Project Start
2000-09-13
Project End
2015-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
15
Fiscal Year
2014
Total Cost
$251,041
Indirect Cost
$47,575
Name
University of Texas MD Anderson Cancer Center
Department
Miscellaneous
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Rosenberg, Abby R; Bradford, Miranda C; McCauley, Elizabeth et al. (2018) Promoting resilience in adolescents and young adults with cancer: Results from the PRISM randomized controlled trial. Cancer 124:3909-3917
Sahin, Ismet; Zhang, Yu; McAllister, Florencia (2018) Tumor Spheres Quantification with Smoothed Euclidean Distance Transform. J Mol Imaging Dyn 8:
Bannon, Sarah A; Montiel, Maria F; Goldstein, Jennifer B et al. (2018) High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Cancer Prev Res (Phila) 11:679-686
MD Anderson Head and Neck Cancer Symptom Working Group; Kamal, Mona; Rosenthal, David I et al. (2018) Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol 126:75-80
Zhang, Hua; Sturgis, Erich; Zhu, Lijun et al. (2018) The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy. Transl Oncol 11:633-638
Joint Head and Neck Radiotherapy-MRI Development Cooperative (2018) Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers. Sci Data 5:180008
Roland, Christina L; Bednarski, Brian K; Watson, Kelsey et al. (2018) Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol 117:879-885
Keung, Emily Z; Chiang, Yi-Ju; Voss, Rachel K et al. (2018) Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol 44:170-177
Jalloul, Randa J; Nick, Alpa M; Munsell, Mark F et al. (2018) The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer. J Gynecol Oncol 29:e68
Barcenas, Carlos H; Shafaee, Maryam N; Sinha, Arup K et al. (2018) Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer. J Natl Compr Canc Netw 16:518-524

Showing the most recent 10 out of 210 publications